Total Payments
$331.61
2023 Payments
$16.47
Companies
11
Transactions
16
Medicare Patients
459
Medicare Billing
$35,066
Payment Breakdown by Category
Food & Beverage$331.61 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $331.61 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $72.02 | 1 | $0 (2017) |
| Novo Nordisk Inc | $41.10 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41.00 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.21 | 3 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $25.65 | 2 | $0 (2021) |
| Esperion Therapeutics, Inc. | $24.35 | 2 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $21.89 | 1 | $0 (2021) |
| AbbVie Inc. | $21.27 | 1 | $0 (2021) |
| Phadia US Inc. | $16.47 | 1 | $0 (2023) |
| Inogen, Inc. | $16.32 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16.47 | 1 | Phadia US Inc. ($16.47) |
| 2022 | $13.33 | 1 | Biohaven Pharmaceutical Holding Company Ltd. ($13.33) |
| 2021 | $188.79 | 12 | Novo Nordisk Inc ($41.10) |
| 2019 | $41.00 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($41.00) |
| 2017 | $72.02 | 1 | SANOFI-AVENTIS U.S. LLC ($72.02) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/01/2023 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Allergy/Immunology | ||||||
| 11/07/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: PRIMARY CARE | ||||||
| 10/15/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardio-renal | ||||||
| 08/12/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/05/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: UROLOGY | ||||||
| 07/29/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 06/17/2021 | Inogen, Inc. | InogenOne (Device) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: Oxygen Concentrator | ||||||
| 05/06/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.32 | General |
| 04/29/2021 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: CNS | ||||||
| 04/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/11/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $41.00 | General |
| 02/16/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $72.02 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 152 | 199 | $68,272 | $8,977 |
| 2022 | 3 | 98 | 159 | $53,849 | $9,758 |
| 2021 | 2 | 94 | 116 | $35,793 | $5,855 |
| 2020 | 3 | 115 | 179 | $33,638 | $10,476 |
Total Patients
459
Total Services
653
Medicare Billing
$35,066
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 89 | $37,231 | $4,333 | 11.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $10,800 | $1,848 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 39 | $10,608 | $1,570 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,839 | $922.23 | 11.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $1,365 | $183.75 | 13.5% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 11 | 13 | $429.00 | $119.90 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 83 | $31,535 | $5,587 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 64 | $15,738 | $3,009 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $6,576 | $1,163 | 17.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 62 | $22,896 | $3,664 | 16.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 54 | $12,897 | $2,190 | 17.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 104 | $21,008 | $5,995 | 28.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 39 | 39 | $7,878 | $3,341 | 42.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 22 | 36 | $4,752 | $1,139 | 24.0% |
About Dr. Duyen Kirkpatrick, DO
Dr. Duyen Kirkpatrick, DO is a Family Medicine healthcare provider based in North Ridgeville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1174902480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Duyen Kirkpatrick, DO has received a total of $331.61 in payments from pharmaceutical and medical device companies, with $16.47 received in 2023. These payments were reported across 16 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($331.61).
As a Medicare-enrolled provider, Kirkpatrick has provided services to 459 Medicare beneficiaries, totaling 653 services with total Medicare billing of $35,066. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location North Ridgeville, OH
- Active Since 05/20/2015
- Last Updated 02/03/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174902480
Products in Payments
- SOLIQUA (Drug) $72.02
- TRINTELLIX (Drug) $38.21
- NEXLETOL (Drug) $24.35
- Kerendia (Drug) $21.89
- QULIPTA (Drug) $21.27
- ImmunoCAP (Device) $16.47
- InogenOne (Device) $16.32
- APTIOM (Drug) $14.17
- NURTEC ODT (Drug) $13.33
- GEMTESA (Drug) $11.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.